First characterization of fluoroquinolone resistance in Streptococcus suis

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 2, 2007, Pages 777-782

  Escudero, Jose Antonio ^a   Millan, Alvaro San ^a   Catalan, Ana ^a   De La Campa, Adela G ^b   Rivero, Estefania ^a   Lopez, Gema ^a   Dominguez, Lucas ^a   Moreno, Miguel Angel ^a   Gonzalez Zorn, Bruno ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; LEVOFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; GENE SEQUENCE; GYRA GENE; HORIZONTAL GENE TRANSFER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; POINT MUTATION; PRIORITY JOURNAL; STREPTOCOCCUS SUIS;

AMINO ACID SEQUENCE; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; GENES, BACTERIAL; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POINT MUTATION; RNA, RIBOSOMAL, 16S; SEQUENCE ALIGNMENT; STREPTOCOCCUS SUIS;

EID: 33846708216     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00972-06     Document Type: Article

References (35)

1. Aarestrup, F. M., S. R. Rasmussen, K. Artursson, and N. E. Jensen. 1998. Trends in the resistance to antimicrobial agents of Streptococcus suis isolates from Denmark and Sweden. Vet. Microbiol. 63:71-80.
2. Alonso, R., M. Galimand, and P. Courvalin. 2002. parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513. Antimicrob. Agents Chemother. 46:3686-3687.
3. Balsalobre, L., M. J. Ferrándiz, J. Liñares, F. Tubau, and A. G. de la Campa. 2003. Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:2072-2081.
4. Bartual, S. G., H. Seifert, C. Hippler, M. A. Luzon, H. Wisplinghoff, and F. Rodriguez-Valera. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382-4390.
5. Berthelot-Herault, F., C. Marois, M. Gottschalk, and M. Kobisch. 2002. Genetic diversity of Streptococcus suis strains isolated from pigs and humans as revealed by pulsed-field gel electrophoresis. J. Clin. Microbiol. 40:615-619.
6. Drlica, K., and X. Zhao. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392.
7. el Amin, N. A., S. Jalal, and B. Wretlind. 1999. Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 43:947-949.
8. Ferrándiz, M. J., A. Fenoll, J. Linares, and A. G. de la Campa. 2000. Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:840-847.
9. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol. Microbiol. 13:641-653.
10. Fournier, B., X. Zhao, T. Lu, K. Drlica, and D. C. Hooper. 2000. Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis. Antimicrob. Agents Chemother. 44:2160-2165.
11. Gill, M. J., N. P. Brenwald, and R. Wise. 1999. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:187-189.
12. Godreuil, S., M. Galimand, G. Gerbaud, C. Jacquet, and P. Courvalin. 2003. Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob. Agents Chemother. 47:704-708.
13. González, I., M. Georgiou, F. Alcaide, D. Balas, J. Linares, and A. G. de la Campa. 1998. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci. Antimicrob. Agents Chemother. 42:2792-2798.
14. Huang, W. M. 1996. Bacterial diversity based on type II DNA topoisomerase genes. Annu. Rev. Genet. 30:79-107.
15. Jorgensen, J. H., L. M. Weigel, M. J. Ferraro, J. M. Swenson, and F. C. Tenover. 1999. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Antimicrob. Agents Chemother. 43:329-334.
16. Kanematsu, E., T. Deguchi, M. Yasuda, T. Kawamura, Y. Nishino, and Y. Kawada. 1998. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis. Antimicrob. Agents Chemother. 42:433-435.
17. Kataoka, Y., C. Sugimoto, M. Nakazawa, and M. Kashiwazaki. 1991. Detection of Streptococcus suis type 2 in tonsils of slaughtered pigs using improved selective and differential media. Vet. Microbiol. 28:335-342.
18. Kawamura, Y., H. Fujiwara, N. Mishima, Y. Tanaka, A. Tanimoto, S. Ikawa, Y. Itoh, and T. Ezaki. 2003. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob. Agents Chemother. 47:3605-3609.
19. Kimura, M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:111-120.
20. Kotetishvili, M., A. Kreger, G. Wauters, J. G. Morris, Jr., A. Sulakvelidze, and O. C. Stine. 2005. Multilocus sequence typing for studying genetic relationships among Yersinia species. J. Clin. Microbiol. 43:2674-2684.
21. Kumar, S., K. Tamura, and M. Nei. 2004. MEGA 3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5:50-163.
22. Li, Z., T. Deguchi, M. Yasuda, T. Kawamura, E. Kanematsu, Y. Nishino, S. Ishihara, and Y. Kawada. 1998. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis. Antimicrob. Agents Chemother. 42:3293-3295.
23. Munoz, R., and A. G. de la Campa. 1996. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob. Agents Chemother. 40:2252-2257.
24. National Committee for Clinical Laboratory Standards. 2004. Performance Standards for antimicrobial disk and dilution susceptibility test for bacteria isolated from animals: informational supplement M31-S1. National Committee for Clinical Laboratory Standards, Wayne, Pa.
25. Okwumabua, O., M. O'Connor, and E. Shull. 2003. A polymerase chain reaction (PCR) assay specific for Streptococcus suis based on the gene encoding the glutamate dehydrogenase. FEMS Microbiol. Lett. 218:79-84.
26. Pan, X. S. And L. M. Fisher. 1998. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2810-2816.
27. Pletz, M. W., L. McGee, B. Beall, C. G. Whitney, and K. P. Klugman. 2005. Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States. Antimicrob. Agents Chemother. 49:779-780.
28. Pletz, M. W., L. McGee, C. A. Van Beneden, S. Petit, M. Bardsley, M. Barlow, and K. P. Klugman. 2006. Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer. Antimicrob. Agents Chemother. 50:943-948.
29. Tang, J., C. Wang, Y. Feng, W. Yang, H. Song, Z. Chen, H. Yu, X. Pan, X. Zhou, H. Wang, B. Wu, H. Wang, H. Zhao, Y. Lin, J. Yue, Z. Wu, X. He, F. Gao, A. H. Khan, J. Wang, G. P. Zhao, Y. Wang, X. Wang, Z. Chen, and G. F. Gao. 2006. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med. 3:e151.
30. Vela, A. I., J. Goyache, C. Tarradas, I. Luque, A. Mateos, M. A. Moreno, C. Borge, J. A. Perea, L. Domínguez, and J. F. Fernández-Garayzabal. 2003. Analysis of genetic diversity of Streptococcus suis clinical isolates from pigs in Spain by pulsed-field gel electrophoresis. J. Clin. Microbiol. 41:2498-2502.
31. Wangkaew, S., R. Chaiwarith, P. Tharavichitkul, and K. Supparatpinyo. 2006. Streptococcus suis infection: a series of 41 cases from Chiang Mai University Hospital. J. Infect. 52:455-460.
32. Willenburg, K. S., D. E. Sentochnik, and R. N. Zadoks. 2006. Human Streptococcus suis meningitis in the United States. N. Engl. J. Med. 354:1325.
33. Wisselink, H. J., K. T. Veldman, C. Van den Eede, S. A. Salmon, and D. J. Mevius. 2006. Quantitative susceptibility of Streptococcus suis strains isolated from diseased pigs in seven European countries to antimicrobial agents licensed in veterinary medicine. Vet. Microbiol. 113:73-82.
34. World Health Organization. August 2005, posting date. Fact sheets: Streptococcus suis. World Health Organization, Geneva, Switzerland. [Online.] http://www.wpro.who.int/media_centre/fact_sheets/fs_20050802.htm.
35. Yu, H., H. Jing, Z. Chen, H. Zheng, X. Zhu, H. Wang, S. Wang, L. Liu, R. Zu, L. Luo, N. Xiang, H. Liu, X. Liu, Y. Shu, S. S. Lee, S. K. Chuang, Y. Wang, J. Xu, W. Yang, and Streptococcus suis study groups. 2006. Human Streptococcus suis outbreak, Sichuan, China. Emerg. Infect. Dis. 12:914-920.